Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

3 clinical trials · 3 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Karuna Therapeutics, Inc., a Bristol Myers Squibb company

RECRUITINGPhase 3NCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis...

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056. Subjects (randomized...

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyEnrolling: 80020 locations
Psychosis Associated With Alzheimer's Disease
RECRUITINGPhase 3NCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and...

The purpose of this study is to evaluate the long-term safety and tolerability of KarXT and KarX-EC for the treatment of Schizophrenia and autism-related irritability in...

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyEnrolling: 40020 locations
SchizophreniaAutism-Related Irritability
RECRUITINGPhase 3NCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis...

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyEnrolling: 40620 locations
Alzheimer Disease